MassDevice Q&A
Q&A Features
08/27/2012
by
Arezu Sarvestani
EnteroMedics CEO Mark Knudson and CFO Greg Lea tell MassDevice.com about the company's Maestro weight loss pacemaker and how a twist on neuromodulation may help patients eat less and feel full without anatomy-altering surgery.
EnteroMedics (NSDQ:ETRM) is looking to control metabolic disease by attacking the problem closer to its source - human behavior.
"We tried to understand why people became over-weight and obese, and what was the underlying...
08/16/2012
by
Arezu Sarvestani
The best way to beat Intuitive Surgical out of the corner it has on the prostate cancer treatment market is by amping up the aggression, radiosurgery veteran and Varian chief medical officer John Adler tells MassDevice.com.
07/16/2012
by
Sony Salzman
MassDevice discusses medical devices for mobile phones and the future of networked patient care with Dr. Leslie Saxon, cardiology chief at the University of Southern California.
As cardiology chief of the Keck School of Medicine at the University of Southern California, Dr. Leslie Saxon is spearheading a successful mobile health innovation center called the Center for Body Computing. Founded in 2010, the coalition works with engineers, device companies and thought leaders to develop mobile health software and apps.
Saxon's ultimate goal is to create a single platform that is the "epicenter of wireless health." The CBC...
07/09/2012
by
Arezu Sarvestani
OptiMedica CEO Mark Forchette tells MassDevice why femtosecond laser technology is changing the game in cataract surgery and how the promise of the technology lured him away from steady path at the largest ophthalmology company.
Updated: July 18, 2012 11:30 a.m.
OptiMedica Corp. is making waves and challenging the leaders in global eye care with its Catalys Precision Laser system for cataract surgery and CEO Mark Forchette isn't shy about extolling his company's potential.
The Catalys system, which won FDA clearance in December 2011 and CE Mark approval in the European Union in August 2011, performs key incisions during cataract...
07/02/2012
by
Arezu Sarvestani
Veniti founder, president & CEO Sean Morris tells MassDevice how he intends to conquer the venous disease space with a 3-pronged approach partially inspired by Julius Caesar.
Veniti founder, president & CEO Sean Morris is on the march, looking to take over venous disease treatment with a suit of specialized devices that he hopes will knock out their more generic forebears.
Veniti, formed in 2009, specializes in...
06/26/2012
by
Arezu Sarvestani
Venture capitalists are no longer looking for a safe bet - they're on the hunt for disrupters. Managing directors from venture capital firms tell MassDevice where they're looking to place their limited resources and why the old "play-it-safe" model was broken.
The seas are changing for medical device investment.
Venture capitalists are looking at their investment strategies since the 1990s and seeing a broken model focused on funding the familiar, placing safe bets in "incremental" devices...
RECENT BLOG POSTS
- Is Valeant About To Make A Bold Bid For Bausch & Lomb?
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
